Pyrimidine Nucleos(t)ide Therapy in Patients With Thymidine Kinase 2 Deficiency

20254 citationsJournal Articlehybrid Open Access

Authors

This study provides Class III evidence for a reduction in the risk of death in patients with TK2d treated with pyrimidine nucleos(t)ides.

Published in: Neurology

Volume 105, Issue 6, pp. e213908-e213908

Field-Weighted Citation Impact: 3.23